Smartphone Application for University Students With Binge Drinking Behavior
NCT ID: NCT06084832
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
628 participants
INTERVENTIONAL
2023-10-01
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotion Regulation Interventions for Preventing Collegiate Escalations in Drinking
NCT04492982
Multi-Component Breath Alcohol Intervention
NCT06124898
Reducing Hazardous Alcohol Use in Social Networks Using Targeted Intervention
NCT02895984
Integrative Alcohol and Risky Sex Feedback for College Students
NCT05011903
Web-based Personalized Feedback for University Students
NCT01521078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Binge Drinking
blood microsampling
blood microsampling for the measure of Phosphatidylethanol
Binge Drinking-control
blood microsampling
blood microsampling for the measure of Phosphatidylethanol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood microsampling
blood microsampling for the measure of Phosphatidylethanol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* AUQ score greater than or equal to 24, and AUDIT score greater than or equal to 3 for its first 3 items. Drinking details with the DDQ when necessary.
* BD behavior: at least one occasion with 6 or more drinks in the last 3 months.
* Consent to be included in the study
* Affiliated to social security
Exclusion Criteria
* Previous use of the MyDéfi smartphone application
* Declaration of a psychiatric / neurologic condition
* Pregnant, parturient or breastfeeding woman
* Subject under guardianship, curators or restricted under public law
18 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
EPSM Marne, Reims
UNKNOWN
SCA-LAB UMR-CNRS 9193, Lille
UNKNOWN
Paul Valery University, Montpellier
UNKNOWN
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, Picardie, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Andre C, Sauton P, Dreinaza M, Diouf M, Bodeau S, Martinetti M, Trouillet R, de Groote C, Nandrino JL, Alexandre A, Benzerouk F, Gierski F, Perney P, Grellet L, Andre J, Naassila M. Effect of the MyDefi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double-Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker-The SMARTBINGE Trial. Int J Methods Psychiatr Res. 2025 Jun;34(2):e70014. doi: 10.1002/mpr.70014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2023_843_0069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.